Cart
sales@molnova.com
Exherin
CAS No. 229971-81-7
Exherin ( ADH-1 )
Catalog No. M13640 CAS No. 229971-81-7
Exherin (ADH-1) is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 77 | In Stock |
|
| 10MG | 128 | In Stock |
|
| 25MG | 230 | In Stock |
|
| 50MG | 383 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameExherin
-
NoteResearch use only, not for human use.
-
Brief DescriptionExherin (ADH-1) is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities.
-
DescriptionExherin (ADH-1) is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities; selectively and competitively binds to and blocks N-cadherin.
-
SynonymsADH-1
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number229971-81-7
-
Formula Weight570.69
-
Molecular FormulaC22H34N8O6S2
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CN=CN2)NC(=O)C)C(=O)N)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Perotti A, et al. Ann Oncol. 2009 Apr;20(4):741-5.
molnova catalog
related products
-
Ioversol
Ioversol is a nonionic iodinated contrast agent.
-
Melamine
Melamine is a widely-used intermediate mainly employed as a raw material for producing melamine resin. It is also a metabolite of cyromazine formed in the body of mammals who have ingested cyromazine.
-
3-Amino-2-oxazolidin...
3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone. It is always be detected as a indicator of furazolidone residues in vivo.
